DEWPOINT Trademark
Trademark Overview
On Wednesday, February 15, 2023, a trademark application was filed for DEWPOINT with the United States Patent and Trademark Office. The USPTO has given the DEWPOINT trademark a serial number of 97796171. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, June 3, 2025. This trademark is owned by Dewpoint Therapeutics, Inc.. The DEWPOINT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Reagents for clinical use in the nature of clinical medical use
Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use in the nature of diagnostic reagents for clinical and medical laboratory use
General Information
| Serial Number | 97796171 |
| Word Mark | DEWPOINT |
| Filing Date | Wednesday, February 15, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, June 3, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 9, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Reagents for clinical use in the nature of clinical medical use |
| Pseudo Mark | DEW POINT |
| Goods and Services | Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use in the nature of diagnostic reagents for clinical and medical laboratory use |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 6, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 6, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Dewpoint Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Party Name | Dewpoint Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Saturday, February 18, 2023 | NEW APPLICATION ENTERED |
| Monday, March 6, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 27, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 14, 2023 | ASSIGNED TO EXAMINER |
| Monday, November 27, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, November 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, February 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 9, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, December 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, December 2, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, December 3, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, June 3, 2025 | SOU EXTENSION 2 FILED |
| Tuesday, June 3, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 3, 2025 | SOU EXTENSION 2 GRANTED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
